A groundbreaking study led by Li Yi, professor at the School of Life Sciences, was published in Nature on March 12, titled "Perception of viral ...

OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025: OXB (LSE: ...

Hyderabad: Bharat Biotech International Limited (BBIL), has announced the launch of India's only vertically integrated, ...

HYDERABAD: Vaccine manufacturer Bharat Biotech International Limited (BBIL) is making a foray into the cell and gene therapy ...

Bharat Biotech aims to democratize gene therapies, traditionally considered prohibitively expensive and available primarily ...

A new study has uncovered a molecular mechanism by which rice cells perceive viral infections and initiate antiviral response ...

BBIL's 50,000-square-foot CGT facility advances its mission to deliver life-saving treatments for haematological malignancies ...

Hyderabad: Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and ...

Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...